Add-the-sample and go! Piccolo® reagent panels make testing easy.
Spend your valuable time on patient consultations.
With the Piccolo’s speed and broad menu of lab-accurate1 chemistry tests, care providers can diagnose and plan treatment in a single visit – thereby helping to increase case efficiency, practice throughput, patient satisfaction2 and staff efficiency.
Reimbursable Panels
In the US and other world markets with multi-payer systems, Piccolo panels are reimbursed by most private insurers and by government healthcare agencies. Combined with greater efficiencies in care delivery and improved outcomes, the Piccolo can contribute to overall practice profitability.
Summary and Explanation of Tests
| Panel-Test | Description / Panels | |
|---|---|---|
| Albumin | ALB |
Liver and kidney diseases.
|
| Alkaline phosphatase | ALP |
Liver, bone, parathyroid, and intestinal diseases
|
| Alanine aminotransferase | ALT |
Liver diseases, including viral hepatitis and cirrhosis; heart diseases.
|
| Amylase | AMY |
Pancreatitis.
|
| Aspartate aminotransferase | AST |
Liver disease including hepatitis and viral jaundice, shock.
|
| Blood Urea Nitrogen | BUN | |
| Calcium | Ca |
Parathyroid, bone and chronic renal diseases; tetany.
|
| Total Cholesterol | CHOL | |
| Total Cholesterol/HDL Ratio [Calculated] | CHOL/HDL* | |
| Creatine Kinase | CK |
Myocardial infarction, progressive muscular dystrophy, dermatomyositis,
rhabdomyolysis due to drug ingestion, hyperosmolality, autoimmune disease,
delirium tremens, convulsions, Crush syndrome, hypothyroidism, surgery, severe
exercise, intramuscular injection, physical inactivity, decreased muscle mass.
|
| Chloride | Cl- |
Dehydration, prolonged diarrhea and vomiting, renal tubular disease, hyperparathyroidism, burns, salt-losing renal diseases, over hydration and thiazide therapy.
|
| Creatinine | CRE |
Renal disease and monitoring of renal dialysis.
|
| C-Reactive Protein | CRP |
Infection, tissue injury, and inflammatory disorders.
|
| Direct bilirubin | DBIL |
Liver disorders, hemolytic hematological, and metabolic disorder,
including hepatitis and gall bladder obstruction.
|
| Estimated Glomerular Filtration Rate [Calculated] | eGFR* |
Identify individuals with reduced kidney function and help facilitate the detection of CKD.
|
| Gamma glutamyltransferase | GGT |
Liver diseases, including alcoholic cirrhosis and primary and secondary liver tumors.
|
| Glucose | GLU |
Carbohydrate metabolism disorders, including adult and juvenile diabetes mellitus
and hypoglycemia
|
| High-Density Lipoprotein Cholesterol | HDL | |
| Potassium | K+ |
Renal glomerular or tubular disease, adrenocortical insufficiency, diabetic ketacidosis, excessive intravenous potassium therapy, sepsis, panhypopituitarism, in vitro hemolysis, hyperaldosteronism, malnutrition, hyperinsulinism, metabolic alkalosis and gastrointestinal loss.
|
| Lactate | LAC |
Lactate measurements are used in the diagnosis and treatment of lactate acidosis, monitoring tissue hypoxia, and diagnosis of hyperlactatemia.
|
| Lactate-Dehydrogenase | LDH | |
| Low Density Lipo Protein* | LDL* | |
| Magnesium | Mg |
Hypomagnesemia and hypermagnesemia.
|
| Sodium | Na |
Dehydration, diabetes insipidus, loss of hypotonic gastrointestinal fluids, salt
poisoning, selective depression of sense of thirst, skin losses, burns, sweating,
hyperaldosteronism, CNS disorders, dilutional, depletional and delusional
hyponatremia and syndrome of inappropriate ADH secretion.
|
| Sodium | Na+ |
Dehydration, diabetes insipidus, loss of hypotonic gastrointestinal fluids, salt
poisoning, selective depression of sense of thirst, skin losses, burns, sweating,
hyperaldosteronism, CNS disorders, dilutional, depletional and delusional
hyponatremia and syndrome of inappropriate ADH secretion.
|
| Non-HDL [Calculated] | nHDLc* | |
| Phosphorus | PHOS |
Dehydration, diabetes, parathyroidism, and renal disease.
|
| Total bililrubin | TBIL |
Liver disorders, including hepatitis and gall bladder obstruction; jaundice.
|
| Total carbon dioxide | tCO₂ |
Primary metabolic alkalosis and acidosis and primary respiratory alkalosis and acidosis.
|
| Total protein | TP |
Liver, kidney, bone marrow diseases; metabolic and nutritional disorders.
|
| Triglycerides | TRIG | |
| Uric Acid | UA |
Renal and metabolic disorders, including renal failure and gout.
|
| Very Low Density Lipo Protein* | VLDL* |
“The technology inside the Piccolo® is genius. What Abaxis® has been able to accomplish with just an 8cm plastic disc… it can literally transform healthcare.”
David Seccombe
President and CEO CEQAL
-
-
- References:
- 1 Data on file.
- 2 Patient satisfaction with point-of-care laboratory testing: report of a quality improvement program in an ambulatory practice of an academic medical center, 2013, Crocker et al.
- * Disclaimer: Amlyte 13 is not available in the US. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your local representative if you have questions about the availability of specific Abaxis products in your area.
-